Jun Kang

Jun Kang practices at Quest Diagnostics Incorporated in Clifton, New Jersey.

Jun Kang's NPI, 1043469042, was assigned on September 15, 2008. Jun Kang holds Michigan license 4301090408.

Jun Kang's primary practice is Quest Diagnostics Incorporated, at 881 Allwood Rd, Clifton, NJ 07012 in Passaic County. The practice phone is (862) 349-2010.

Jun Kang's primary practice is Quest Diagnostics Incorporated in Clifton, New Jersey. The medical group on file is Access Health Medical PC. Dmand AI also links Jun Kang to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jun Kang practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is Jun Kang's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Jun Kang is licensed in Michigan.

CMS data shows 405 Medicare services from Jun Kang across 5 procedure codes in 2024, for 55 Medicare patients. Medicare paid $29,070 for them. Every service was in an office.

CMS counts 55 Medicare patients who saw Jun Kang in 2024. The largest group is 65 to 74, with 42 patients. 56% of them have high cholesterol, and 45% have high blood pressure. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jun Kang's median patient age at 53, with 57% women.

In 2024, Jun Kang wrote 1,025 Medicare Part D claims for 228 patients. 85% of them were for generic drugs. CMS names the drug for 701 of them, across 21 drugs with 11 or more claims each, at $36,962 in total drug cost. In 2023, CMS named 927 claims across 28 drugs.

Jun Kang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 13 general payments to Jun Kang from 4 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $234.